Janney Montgomery Scott’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.98M | Buy |
47,404
+4,958
| +12% | +$345K | 0.01% | 1085 |
|
|
2025
Q4 | $2.82M | Sell |
42,446
-14,865
| -26% | -$961K | 0.01% | 1173 |
|
|
2025
Q3 | $3.86M | Buy |
57,311
+14,244
| +33% | +$1.13M | 0.01% | 996 |
|
|
2025
Q2 | $3.76M | Sell |
43,067
-195,357
| -82% | -$15.3M | 0.01% | 925 |
|
|
2025
Q1 | $16.3M | Buy |
238,424
+5,881
| +3% | +$480K | 0.05% | 385 |
|
|
2024
Q4 | $18.1M | Buy |
232,543
+222,548
| +2,227% | +$16.5M | 0.05% | 368 |
|
|
2024
Q3 | $670K | Sell |
9,995
-13,060
| -57% | -$1.07M | ﹤0.01% | 1766 |
|
|
2024
Q2 | $2.61M | Sell |
23,055
-5,804
| -20% | -$734K | 0.01% | 972 |
|
|
2024
Q1 | $4M | Sell |
28,859
-3,012
| -9% | -$379K | 0.01% | 840 |
|
|
2023
Q4 | $3.95M | Sell |
31,871
-4,294
| -12% | -$439K | 0.01% | 817 |
|
|
2023
Q3 | $3.37M | Sell |
36,165
-21,505
| -37% | -$2.42M | 0.01% | 817 |
|
|
2023
Q2 | $7.41M | Buy |
57,670
+13,061
| +29% | +$1.58M | 0.03% | 558 |
|
|
2023
Q1 | $5.18M | Sell |
44,609
-1,233
| -3% | -$138K | 0.02% | 632 |
|
|
2022
Q4 | $5.19M | Buy |
45,842
+10,597
| +30% | +$1.16M | 0.02% | 661 |
|
|
2022
Q3 | $2.84M | Sell |
35,245
-927
| -3% | -$78.5K | 0.01% | 820 |
|
|
2022
Q2 | $2.7M | Buy |
36,172
+2,708
| +8% | +$247K | 0.01% | 804 |
|
|
2022
Q1 | $4.28M | Buy |
33,464
+3,028
| +10% | +$331K | 0.02% | 640 |
|
|
2021
Q4 | $4.09M | Buy |
30,436
+1,392
| +5% | +$200K | 0.02% | 686 |
|
|
2021
Q3 | $3.97M | Buy |
29,044
+1,528
| +6% | +$193K | 0.02% | 682 |
|
|
2021
Q2 | $2.94M | Buy |
27,516
+16,556
| +151% | +$1.59M | 0.01% | 778 |
|
|
2021
Q1 | $985K | Sell |
10,960
-9,704
| -47% | -$911K | ﹤0.01% | 1195 |
|
|
2020
Q4 | $1.91M | Sell |
20,664
-50,996
| -71% | -$4.55M | 0.01% | 892 |
|
|
2020
Q3 | $7.38M | Sell |
71,660
-3,356
| -4% | -$351K | 0.04% | 368 |
|
|
2020
Q2 | $7.6M | Buy |
75,016
+41,460
| +124% | +$3.71M | 0.05% | 334 |
|
|
2020
Q1 | $2.26M | Sell |
33,556
-11,932
| -26% | -$742K | 0.02% | 652 |
|
|
2019
Q4 | $2.49M | Sell |
45,488
-1,408
| -3% | -$66.8K | 0.02% | 706 |
|
|
2019
Q3 | $1.75M | Sell |
46,896
-2,544
| -5% | -$98.8K | 0.01% | 819 |
|
|
2019
Q2 | $1.85M | Buy |
49,440
+9,428
| +24% | +$296K | 0.01% | 769 |
|
|
2019
Q1 | $1.19M | Buy |
40,012
+16,880
| +73% | +$593K | 0.01% | 933 |
|
|
2018
Q4 | $693K | Buy |
23,132
+5,884
| +34% | +$187K | 0.01% | 1116 |
|
|
2018
Q3 | $617K | Sell |
17,248
-172
| -1% | -$5.33K | 0.01% | 1333 |
|
|
2018
Q2 | $414K | Sell |
17,420
-1,980
| -10% | -$42K | ﹤0.01% | 1491 |
|
|
2018
Q1 | $360K | Buy |
19,400
+1,600
| +9% | +$23.7K | ﹤0.01% | 1511 |
|
|
2017
Q4 | $255K | Buy |
+17,800
| New | +$231K | ﹤0.01% | 1678 |
|
|
2017
Q3 | – | Sell |
-11,836
| Closed | -$216K | – | 1834 |
|
|
2017
Q2 | $216K | Buy |
11,836
+1,000
| +9% | +$18.5K | ﹤0.01% | 1590 |
|
|
2017
Q1 | $230K | Sell |
10,836
-3,144
| -22% | -$61.4K | ﹤0.01% | 1546 |
|
|
2016
Q4 | $209K | Sell |
13,980
-432
| -3% | -$7.65K | ﹤0.01% | 1527 |
|
|
2016
Q3 | $316K | Sell |
14,412
-9,148
| -39% | -$204K | 0.01% | 1168 |
|
|
2016
Q2 | $468K | Buy |
+23,560
| New | +$401K | 0.01% | 548 |
|
|
2016
Q1 | – | Sell |
-10,068
| Closed | -$206K | – | 1302 |
|
|
2015
Q4 | $206K | Buy |
10,068
+468
| +5% | +$9.74K | 0.01% | 1220 |
|
|
2015
Q3 | $206K | Buy |
+9,600
| New | +$214K | 0.01% | 1240 |
|
Other funds holding DXCM
VCM
VPM
Janney Montgomery Scott's DXCM Position: Q1 2026 in Review
Janney Montgomery Scott increased its DexCom (DXCM) stake by 12% in Q1 2026, buying an estimated $345K and bringing the position to 47,404 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #1085.
Janney Montgomery Scott first reported a position in DXCM in Q3 2015 and has held it in 41 quarters since. The position peaked at $18.1M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Janney Montgomery Scott held 47,404 shares of DexCom worth $2.98M as of Q1 2026.
- Janney Montgomery Scott bought 4,958 DexCom shares in Q1 2026, an estimated $345K.
- DexCom made up 0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1085 holding.
- Janney Montgomery Scott first reported a position in DexCom in Q3 2015 and has held it in 41 quarters since.
- Janney Montgomery Scott's DexCom position peaked at $18.1M in Q4 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.